AzTrials
AzTrials

Intensive Care PatientsNCT03714230

Longitudinal Prospective Study in a Mixed ICU Population

An observational study of Intensive Care Patients, run by Oslo University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Longitudinal prospective observational multicenter study in a mixed population of intensive care unit (ICU) patients (n=650). The overall purpose of this research proposal is to increase the knowledge in how pre-morbid condition, symptoms during treatment, and selected clinical variables affect self-reported… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intensive Care Patients
How many people
603 participants
Where
1 siteNorway
Study dates
8 Oct 2018to 1 Jun 2021
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: The sample population is adults patients admitted to the ICU.

Who may be able to join

  • Patients that are > 18 years and
  • Meet the criteria of Norwegian Intensive Register (NIR) for being an intensive care patient. The criteria include any on the following criteria:
  • The need of mechanical ventilation, or
  • The need of continuous inotropi, or
  • 24 hours or more on an ICU, when continuous monitoring is needed, or
  • Dies at the ICU within the first 24 hours, or
  • Transferred to another ICU within the first 24 hours

Who cannot join

  • Re-admissions to the ICU (within 72 hours from last ICU discharge)
  • Pre-defined cognitive deficit (e.g. dementia)
  • Homeless
  • Unable to read and Write Norwegian
  • Not included in the study within the first 48 hours since admission to the ICU

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo Univesity hospital

    Oslo, 0424

Other trials in Norway

About this study

Official title: The Trajectory of Functional Status During the First Year After ICU Admission.

Longitudinal prospective observational multicenter study in a mixed population of intensive care unit (ICU) patients (n=650). The overall purpose of this research proposal is to increase the knowledge in how pre-morbid condition, symptoms during treatment, and selected clinical variables affect self-reported functional status during first year after an ICU admission.

Read the detailed description

For this study data will be collected using self-report questionnaires for the long-term outcome (e.g functional status) and several covariates (e.g., cognition, anxiety and depression, PTSD, QOL, general symptoms, frailty). To retrieve baseline data from prior ICU admission, family members will be used as proxy reporters at inclusion. During treatment in the ICU, patients will be mapped for 5 pre-selected symptoms every day for 7 days, or until death or ICU discharge. Several clinical variables (e.g., SOFA score, pain score, level of sedation, mobilization, medication, mouth care) will be collected daily until maximum 7 days. Follow-up data will be collected at 3, 6 and 12 months after ICU admission using self-report questionnaires.

The predictive value of pre-morbid condition prior to ICU admission on functional status during the first year after an ICU admission will be investigated, when controlled for various clinical and demographic variables. As a secondary analyses, the present study will identify both the occurrence of symptoms as well as the severity and distress of each symptom, while in the ICU. Another secondary outcome that will be measured in this longitudinal study is the association between cognitive function one year after an ICU admission and various mental health variables (PTSD, anxiety and depression).

Keywords
Functional status, Symptoms, Cognitive functioning, QOL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. A cohort study on change of Functional Status during the first year after an ICU admission

    Data on functional status will be collected using PROMS (e.g Katz index and Lawton IADL) at baseline, and then after 3, 6 and 12 months.

    Measured: September 2018- May 2020

Secondary outcomes (3)
  1. The investigation of 5 pre-selected symptoms during the ICU stay

    A modified version of the Patient Symptom Survey (PSS) checklist will be used as self-report by the ICU patient when possible or by the clinical nurse as a proxy reporter.

    Measured: September 2018 - December 2020

  2. Cognitive functioning one year after ICU admission in a mixed ICU population

    Cognitive functioning will be measured using self-report with the Cognitive Failure Questionnaire, and proxy reported by IQCODE and CFQ at baseline.

    Measured: September 2018 - December 2020

  3. Posttraumatic Stress Symptoms one year after ICU admission in a mixed ICU population, and the importance of hope

    Posttraumatic stress symptoms will be measured using self-report with the Impact of event scale-revised questionnaire. Hope will be measured with the Herth Hope Index.

    Measured: January 2020 - December 2021

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2018
  2. Study start8 Oct 2018
  3. Primary completion1 Jun 2021
  4. Study completion1 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
603 participants (actual)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT03714230
Sponsor's protocol ID
2017/990
Status last verified
Apr 2021
First submitted
26 Sep 2018
Last updated
12 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Saltnes-Lillegard C, Rustoen T, Beitland S, Puntillo K, Thoresen M, Hofso K. Subgroups of ICU patients identified by self-reported symptoms - A prospective multicenter study. Intensive Crit Care Nurs. 2024 Oct;84:103761. doi: 10.1016/j.iccn.2024.103761. Epub 2024 Jul 16.

    PubMed 39018966
  • Saltnes-Lillegard C, Rustoen T, Beitland S, Puntillo K, Hagen M, Lerdal A, Hofso K. Self-reported symptoms experienced by intensive care unit patients: a prospective observational multicenter study. Intensive Care Med. 2023 Nov;49(11):1370-1382. doi: 10.1007/s00134-023-07219-0. Epub 2023 Oct 9.

    PubMed 37812229

Questions about this trial

What is this clinical trial studying?

An observational study of Intensive Care Patients, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

A cohort study on change of Functional Status during the first year after an ICU admission (time frame: September 2018- May 2020). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03714230, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in